[ALA] YoY Quarter Result on 31-Mar-2017 [#Q3]

Stock
[ALA] Arovella Therapeutics Limited
Announcement Date
30-Mar-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q3]
Profit Trend
QoQ- 65.82%
YoY- 32.35%
Quarter Report
ALA's Result
ALA's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 106 198 43 1,875 1,511 1,407 1,256 -33.74%
PBT -1,446 -3,925 -2,276 -501 -621 -1,039 -955 7.15%
Tax -328 463 -373 340 383 329 90 -
NP -1,118 -3,462 -1,903 -161 -238 -711 -860 4.46%
Tax Rate - - - - - - - -
Total Cost 1,224 3,660 1,946 2,036 1,749 2,118 2,116 -8.71%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin -1,053.37 -1,748.22 -4,437.93 -8.58 -15.73 -50.56 -68.49 57.63%
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS -0.01 -0.03 -0.04 -0.00 -0.01 -0.02 -0.03 -16.71%
EPS Diluted -0.01 -0.03 -0.04 -0.00 -0.01 -0.02 -0.03 -16.71%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.